Skip to main content

Peer Review reports

From: Cost-utility of triple versus dual inhaler therapy in moderate to severe asthma

Original Submission
1 Sep 2021 Submitted Original manuscript
20 Sep 2021 Reviewed Reviewer Report - Adelmir Souza-machado
12 Nov 2021 Reviewed Reviewer Report
16 Nov 2021 Author responded Author comments - Jefferson Antonio Buendía
17 Nov 2021 Author responded Author comments - Jefferson Antonio Buendía
Resubmission - Version 2
16 Nov 2021 Submitted Manuscript version 2
Publishing
19 Nov 2021 Editorially accepted
5 Dec 2021 Article published 10.1186/s12890-021-01777-z

You can find further information about peer review here.

Back to article page